The enhanced antiproliferative response to combined treatment of trichostatin A with raloxifene in MCF-7 breast cancer cells and its relevance to estrogen receptor β expression

Histone deacetylase inhibitor induced modulation of anti-estrogen therapy

(2009) Scott Thomas et al.   CANCER LETTERS

Estrogen receptor beta in breast cancer—Diagnostic and therapeutic implications

(2009) Johan Hartman et al.   STEROIDS

Selective Inhibition of Histone Deacetylase 2 Silences Progesterone Receptor-Mediated Signaling

(2008) E. Bicaku et al.   CANCER RESEARCH

Epigenetic reprogramming of breast cancer cells by valproic acid occurs regardless of estrogen receptor status

(2008) Lorena Travaglini et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Raloxifene, a selective estrogen receptor modulator, induces mitochondria-mediated apoptosis in human endometrial carcinoma cells

(2008) Shoko Morishima et al.   Medical Molecular Morphology

Differential Regulation of Native Estrogen Receptor-Regulatory Elements by Estradiol, Tamoxifen, and Raloxifene

(2007) Nitzan Levy et al.   MOLECULAR ENDOCRINOLOGY